Serina Therapeutics
SER
51 hedge funds and large institutions have $23.3M invested in Serina Therapeutics in 2019 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 7 reducing their positions, and 15 closing their positions.
171% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 7
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% less ownership
Funds ownership: 0.48% → 0.48% (-0%)
6% less capital invested
Capital invested by funds: $24.8M → $23.3M (-$1.49M)
14% less funds holding
Funds holding: 59 → 51 (-8)
40% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$2.11M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$759K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$253K |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$231K |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$202K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$1.5M |
| 2 |
Axa
Paris,
France
|
-$491K |
| 3 |
PCM
Price Capital Management
Lafayette,
Louisiana
|
-$461K |
| 4 |
Millennium Management
New York
|
-$296K |
| 5 |
DWM
Destination Wealth Management
Walnut Creek,
California
|
-$213K |
SER Hedge Fund Activity: Q2 2019 in Review
51 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Serina Therapeutics (SER) for Q2 2019, worth a combined $23.3M — down 6% from $24.8M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of SER and 9 opened new positions — a net loss of 6 holders — while 7 trimmed existing stakes and 19 added.
The largest buyer was BlackRock, adding an estimated $2.11M. The largest seller was State of Wisconsin Investment Board, exiting entirely with an estimated $1.5M sold.
- 51 institutional investors held Serina Therapeutics (SER) as of Q2 2019, down from 59 in Q1 2019.
- Funds reported $23.3M of Serina Therapeutics stock for Q2 2019, down 6% quarter-over-quarter.
- 9 funds opened new Serina Therapeutics positions in Q2 2019 and 15 closed out, a net change of -6 holders.
- The largest Serina Therapeutics buyer in Q2 2019 was BlackRock, an estimated $2.11M added.
- The largest Serina Therapeutics seller in Q2 2019 was State of Wisconsin Investment Board, an estimated $1.5M sold.
Based on aggregated 13F filings for Q2 2019.